<a href=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPAMED%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMED%20L130000429680&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord>Zoya Demidenko</a>: Scholar in Cancer Biology
<a href=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P>Zoya Demidenko</a> is a recognized investigator connected with the Division of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Earlier, she worked at the National Institutes of Health and New York Medical College, establishing a solid foundation in biomedical study.
Demidenko's scholarly work encompasses several critical fields, encompassing the PI3K/AKT/mTOR molecular pathway, cell cycle regulation, cellular aging, and tumor biology. Currently, she has co-authored over 46 peer-reviewed papers, which have garnered over 4,100 mentions a indicator to the influence of her research.
One of her most notable contributions concerns explaining the mechanisms of cellular senescence. Her studies demonstrated that when the cellular division cycle is blocked but cellular growth proceeds, cells enter senescence. Importantly, <a href=https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/>Zoya Demidenko</a> demonstrated that this shift is pharmacologically suppressed using substances such as rapamycin.
<a href=https://scholargps.com/scholars/59798749410547/zoya-n-demidenko>Zoya Demidenko</a> has additionally brought substantially to cancer treatment research, especially in the field of cyclotherapy a approach designed to protecting normal tissue from chemotherapy while leaving malignant cells susceptible. This method offers major potential for reducing the toxic effects of oncological therapy.
Throughout her career, Demidenko has partnered with leading investigators internationally, such as Dr. Mikhail Blagosklonny. Her work is published in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, <a href=https://www.sciencedirect.com/science/article/abs/pii/037811199400784P>Zoya Demidenko</a> ranks as a widely cited voice in contemporary oncological research, with her discoveries keep to influence our understanding of how cells age, interact with therapy, and how cancer may be more successfully treated.
https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord
|
